27849546|t|Physical Stimulation -Based Osteogenesis: Effect of Secretion In Vitro on Fluid Dynamic Shear Stress of Human Alveolar Bone -Derived Mesenchymal Stem Cells
27849546|a|Human alveolar bone -derived mesenchymal stem cells (hABMSCs) are promising candidates for bone therapies, which have the capacity to differentiate into osteoblasts. Recently, secretion of inducible cytokines and growth factors from mesenchymal stem cells (MSCs) has been discovered, and we also have reported the osteogenic effects of cell physical stimulation. In this study, we investigated the effects of hABMSCs - conditioned secretion media (B-CSM) on osteogenic differentiation of hABMSCs in vitro. Furthermore, we analyzed the B-CSM by proteomics array to identify inducible factors which facilitate osteogenic differentiation. To determine optimal concentration, B-CSM was firstly added at varying amounts (5, 10, 20, 40, and 60%) relative to culture medium. The viability and proliferation of hABMSCs were higher after treating with 5-20% B-CSM to the cells, compared to 40-60%. In addition, the expression of stem cells markers CD146 and STRO-1 was increased in the cells treated with 5-20% B-CSM, but decreased with 40-60%. We also found that B-CSM promoted osteogenic differentiation of hABMSCs such as mineralized nodules were strongly generated by 5-20%. B-CSM was most effective in increasing the expression of Vinculin and osteocalcin (OCN) in osteogenic differentiation of hABMSCs. Taken together, the results of our study ultimately indicate that B-CSM from hABMSCs induced by physical stimulation induce the proliferation and osteogenic differentiation of hABMSCs.
27849546	0	20	Physical Stimulation	T068	C0031817
27849546	28	40	Osteogenesis	T042	C0029433
27849546	42	48	Effect	T080	C1280500
27849546	52	61	Secretion	T038	C0036536
27849546	62	70	In Vitro	T080	C1533691
27849546	74	100	Fluid Dynamic Shear Stress	T070	C1171318
27849546	104	109	Human	T016	C0086418
27849546	110	123	Alveolar Bone	T023	C1440080
27849546	133	155	Mesenchymal Stem Cells	T025	C1257975
27849546	156	161	Human	T016	C0086418
27849546	162	175	alveolar bone	T023	C1440080
27849546	185	207	mesenchymal stem cells	T025	C1257975
27849546	209	216	hABMSCs	T025	C1257975
27849546	247	261	bone therapies	T061	C0947815
27849546	278	286	capacity	T081	C1516240
27849546	290	303	differentiate	T043	C1159974
27849546	309	320	osteoblasts	T025	C0029418
27849546	332	341	secretion	T038	C0036536
27849546	345	354	inducible	T169	C0205263
27849546	355	364	cytokines	T116,T129	C0079189
27849546	369	383	growth factors	T116,T123	C0018284
27849546	389	411	mesenchymal stem cells	T025	C1257975
27849546	413	417	MSCs	T025	C1257975
27849546	470	480	osteogenic	T025	C0222677
27849546	481	491	effects of	T080	C1704420
27849546	492	496	cell	T025	C0007634
27849546	497	517	physical stimulation	T068	C0031817
27849546	537	549	investigated	T169	C1292732
27849546	554	564	effects of	T080	C1704420
27849546	565	572	hABMSCs	T025	C1257975
27849546	575	602	conditioned secretion media	T130	C0162518
27849546	604	609	B-CSM	T130	C0162518
27849546	614	640	osteogenic differentiation	T043	C1159974
27849546	644	651	hABMSCs	T025	C1257975
27849546	652	660	in vitro	T080	C1533691
27849546	678	686	analyzed	T062	C0936012
27849546	691	696	B-CSM	T130	C0162518
27849546	700	716	proteomics array	T063	C1138433
27849546	729	738	inducible	T169	C0205263
27849546	739	746	factors	T169	C1521761
27849546	764	790	osteogenic differentiation	T043	C1159974
27849546	805	812	optimal	T080	C2698651
27849546	813	826	concentration	T081	C1446561
27849546	828	833	B-CSM	T130	C0162518
27849546	846	851	added	T169	C1524062
27849546	863	870	amounts	T081	C1265611
27849546	908	922	culture medium	T130	C0010454
27849546	928	937	viability	T043	C0007620
27849546	942	955	proliferation	T043	C0596290
27849546	959	966	hABMSCs	T025	C1257975
27849546	985	993	treating	T169	C1522326
27849546	1005	1010	B-CSM	T130	C0162518
27849546	1018	1023	cells	T025	C1257975
27849546	1025	1033	compared	T052	C1707455
27849546	1062	1072	expression	T045	C1171362
27849546	1076	1086	stem cells	T025	C1257975
27849546	1087	1094	markers	T201	C0005516
27849546	1095	1100	CD146	T116,T129	C1457876
27849546	1105	1111	STRO-1	T129	C2003357
27849546	1116	1125	increased	T081	C0205217
27849546	1133	1138	cells	T025	C1257975
27849546	1139	1151	treated with	T169	C1522326
27849546	1158	1163	B-CSM	T130	C0162518
27849546	1169	1178	decreased	T081	C0205216
27849546	1211	1216	B-CSM	T130	C0162518
27849546	1226	1252	osteogenic differentiation	T043	C1159974
27849546	1256	1263	hABMSCs	T025	C1257975
27849546	1272	1291	mineralized nodules	T033	C0243095
27849546	1306	1315	generated	T052	C3146294
27849546	1326	1331	B-CSM	T130	C0162518
27849546	1341	1350	effective	T080	C1704419
27849546	1354	1364	increasing	T169	C0442808
27849546	1369	1379	expression	T045	C1171362
27849546	1383	1391	Vinculin	T116,T123	C0085175
27849546	1396	1407	osteocalcin	T116,T123	C0029419
27849546	1409	1412	OCN	T116,T123	C0029419
27849546	1417	1443	osteogenic differentiation	T043	C1159974
27849546	1447	1454	hABMSCs	T025	C1257975
27849546	1476	1483	results	T169	C1274040
27849546	1522	1527	B-CSM	T130	C0162518
27849546	1533	1540	hABMSCs	T025	C1257975
27849546	1552	1572	physical stimulation	T068	C0031817
27849546	1584	1597	proliferation	T043	C0596290
27849546	1602	1628	osteogenic differentiation	T043	C1159974
27849546	1632	1639	hABMSCs	T025	C1257975